Vascular endothelial growth factors and thyroid disorders

Endocrine Journal

Volumn 48, Issue 6, 2001, Pages 635-646

  Sato, K ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Cyst fluid; Graves' disease; Iodide; Thyroid carcinoma; Vascular endothelial growth factor (VEGF)

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOSTATIN; BASIC FIBROBLAST GROWTH FACTOR; ENDOSTATIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 12; INTERLEUKIN 8; IODIDE; SCATTER FACTOR; THROMBOSPONDIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VASCULOTROPIN ANTIBODY; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

ANAPLASTIC THYROID CARCINOMA; CANCER INHIBITION; CYST FLUID; GRAVES DISEASE; METASTASIS; ORGAN BLOOD FLOW; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REVIEW; THYROID CARCINOMA; THYROID CYST; THYROID DISEASE; THYROID FOLLICLE; THYROID FUNCTION; THYROID PAPILLARY CARCINOMA; TRANSCRIPTION REGULATION;

EID: 0035677567     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.48.635     Document Type: Review

References (57)

1. Role of vascular endothelial growth factor in regulation of physiological angiogenesis
2. Vascular endothelial growth factor and the regulation of angiogenesis
3. Color-flow Doppler sonography in Graves' disease: "Thyroid inferno"
4. Clinical characteristics of amiodarone-induced thyrotoxicosis and hypothyroidism in Japan
5. Blood capillary enlargement during the development of thyroid hyperplasia in the rat
6. Mitosis in thyroid follicular epithelial cells in vivo. III. Cytokinesis
7. Ultrastructural aspects of capillary fusion during the development of thyroid hyperplasia
8. Structure and function of vascular endothelial growth factor receptor-1 and -2
9. Suspension culture of separated follicles consisting of differentiated thyroid epithelial cells
10. 125I organification and thyroid hormone release by interleukin-1, tumor necrosis factor-α, interferon-γ in human thyrocytes in suspension culture
11. 125I incorporation and de novo-synthesized thyroid hormone release in human thyroid follicles
12. Interleukin-6 (IL-6) inhibits thyroid function in the presence of soluble IL-6 receptor in cultured human thyroid follicles
13. Stimulation of thyroid stimulating hormone and Graves' immunoglobulin G of vascular endothelial growth factor mRNA expression in vitro and flt mRNA expression in the rat thyroid in vivo
14. Upregulation of the angiogenic factors PlGF, VEGF and their receptors (Flt-1, Flk-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization
15. Expression of vascular endothelial growth factor (VEGF) and VEGF receptor-1 (Flt-1) in Graves disease possibly correlated with increased vascular density
16. The thyroid gland
17. Thyroid-stimulating hormone promotes the secretion of vascular endothelial growth factor in thyroid cancer cell lines
18. Increased serum vascular endothelial growth factor levels and intrathyroidal vascular area in patients with Graves' disease and Hashimoto's thyroiditis
19. Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1
20. Intrathyroidal cytokine gene expression in Hashimoto's thyroiditis
21. Vascular endothelial growth factor gene and protein: Strong expression in thyroiditis and thyroid carcinoma
22. Tie-2 is expressed on thyroid follicular cells, is increased in goiter, and is regulated by thyrotropin through cyclic adenosine 3′,5′-monophosphate
23. Angiogenesis in the thyroid gland
24. Increased concentration of vascular endothelial growth factor/vascular permeability factor in cyst fluid of enlarging and recurrent thyroid nodules
25. Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PlGF) associated with malignancy in human thyroid tumors and cell lines
26. Vascular endothelial growth factor expression is higher in differentiated thyroid cancer than in normal or benign thyroid
27. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features
28. The expression of vascular endothelial growth factor and the type 1 vascular endothelial growth factor receptor correlate with the size of papillary thyroid carcinoma in children and young adults
29. Increased expression of the vascular endothelial growth factor is a pejorative prognosis marker in papillary thyroid carcinoma
30. Intensity of vascular endothelial growth factor expression is associated with increased risk of recurrence and decreased disease-free survival in papillary thyroid cancer
31. Pathology
32. Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis
33. Novel VEGF family members: VEGF-B, VEGF-C and VEGF-D
34. Vascular endothelial growth factor-C gene expression in papillary and follicular thyroid carcinoma
35. VEGFc and VEGFR3 expression in human thyroid pathologies
36. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth
37. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis
38. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
39. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer
40. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis
41. Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma
42. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis
43. Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis
44. Overexpression of vascular endothelial growth factor C is related to lymphogenous metastasis in early gastric carcinoma
45. Vascular endothelial growth factor C induces angiogenesis in vivo
46. Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C
47. Regulation of differentiated thyroid function by iodide: Preferential inhibitory effect of excess iodide on thyroid hormone secretion in sheep thyroid cell cultures
48. Amiodarone stimulates interleukin-6 production in cultured human thyrocytes, exerting cytotoxic effects on thyroid follicles in suspension culture
49. Physiology and pharmacology of iodized oil in goiter prophylaxis
50. Iodide induces transforming growth factor beta 1 (TGF-beta 1) mRNA in sheep thyroid cells
51. Regulation of transforming growth factor beta 1 messenger ribonucleic acid expression in porcine thyroid follicles in vitro by growth factors, iodine, or delta-iodolactone
52. Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein
53. The effect of preoperative Lugol's iodine on thyroid blood flow in patients with Graves' hyperthyroidism
54. Inverse relation between iodine intake and thyroid blood flow: Color Doppler flow imaging in euthyroid humans
55. Genes regulated by TSH and iodide in cultured human thyroid follicles: Analysis by cDNA microarray
56. Neutralizing vascular endothelial growth factor activity inhibits thyroid cancer growth in vivo
57. Immunoglobulin G of untreated Graves' patients with or without TSH receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles